ECM
PHGE icon

ExodusPoint Capital Management’s BiomX PHGE Stock Holding History

ExodusPoint Capital Management’s Portfolio PHGE Stock Details PHGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-90
Closed -$120K – 1966
2020
Q1 		$120K Sell
90
-36
-29% -$62.8K 0.01% 863
2019
Q4 		$232K Buy
+126
New +$217K ﹤0.01% 1276

Other funds holding PHGE

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ExodusPoint Capital Management's PHGE Position: Q2 2020 in Review

ExodusPoint Capital Management sold out of BiomX (PHGE) in Q2 2020, closing a stake of 90 shares — an estimated $120K sold.

ExodusPoint Capital Management first reported a position in PHGE in Q4 2019 and held it in 2 quarters. The position peaked at $232K in Q4 2019. 12 funds tracked by Wall St. Rank hold PHGE as of Q2 2020.

  • ExodusPoint Capital Management reported no remaining BiomX position as of Q2 2020 after selling out during the quarter.
  • ExodusPoint Capital Management sold 90 BiomX shares in Q2 2020, an estimated $120K.
  • ExodusPoint Capital Management first reported a position in BiomX in Q4 2019 and held it in 2 quarters.
  • ExodusPoint Capital Management's BiomX position peaked at $232K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held BiomX as of Q2 2020.

Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.